Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-05-18
2009-06-23
Canella, Karen A (Department: 1643)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S012200, C530S300000, C530S324000, C530S402000, C530S820000, C530S822000, C530S823000, C530S825000
Reexamination Certificate
active
07550426
ABSTRACT:
A class of procytotoxic agents is characterized by a capability to kill with target cell-specificity. Such an aspect can be a pore-forming protein which has at least one lysine residue, modified by a peptide linkage to an amino acid residue, via the epsilon amino group, and an acetyl group. These agents are useful in treating cancer, especially prostate cancer.
REFERENCES:
patent: 7232800 (2007-06-01), Sun et al.
patent: WO 01/85777 (2001-11-01), None
Warren et al (Cancer Research, 2001, vol. 61, pp. 6783-6787).
Doi et al (Arhives of Biochemistry and Biophysics, 2001, vol. 395, pp. 85-93).
Blondelle et al., (1991)Biochemistry30: 4671-4678.
Dempsey et al., (1991)FEBS Lett.281: 240-244.
Argiolas, A., and Pisano, J., 1985,J. Biol. Chem.260, 1437-1444.
Young et al., (1982)J. Exp. Med.156: 1677.
Lynch et al., (1982) EMBO J 7: 801.
Young & Cohn, (1985)J. Cell Biol.29: 299.
Rosenberg et al., (1989)Molec. Biochem. Parasit.33: 237.
Jansson et al., (1994)Science263: 1440.
Leippe et al., (1994)Proc. Natl. Acad. Sci. USA91: 2602.
Andra et al.,FEBS Letters, 385 (1996), pp. 96-100.
Shai et al., (1996)J. Biol. Chem.271-7305-7308.
Werkmeister et al. (1993),Biochim. Biophys. Acta1157: 50-54.
Horosczewicz et al. (1983),Cancer Res.43: 1809-1818.
Pinto et al. (1999),The Prostate J.1: 15-26.
Wright et al. (1995),Urol. Oncol.1: 18-28.
Lopes et al., (1990),Cancer Res.50: 623-6428.
Troyer et al.,Int. J. Cancer62: 552-558.
Andreu et al., (1983)Proc. Natl. Acad. Sci USA80: 6475-6479.
Andreu et al., (1985)Biochemistry24: 1683-1688.
Fink et al. (Jun. 1989)Int. J. Peptide Protein Res.33: 412-421.
Fink et al., (1989)J. Biol. Chem.264: 6260-6267.
Wallace, B M, Lasker, J S,Science, 260:912-912 (1992).
Wagner Thomas E.
Yu Xianzhong
Canella Karen A
Foley & Lardner LLP
GHC Research Development Corporation
LandOfFree
Acetylated therapeutic procytotoxins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acetylated therapeutic procytotoxins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acetylated therapeutic procytotoxins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4147437